Current state of image-guided focal therapy for prostate cancer.
Rafael R Tourinho-BarbosaBradford J WoodAndre Luis AbreuBruno NaharToshitaka ShinSelcuk GuvenThomas J PolascikPublished in: World journal of urology (2020)
An increasing number of prospective studies with longer follow-up have been recently published. Acceptable cancer control and low treatment toxicity after FT have been consistently reported. Follow-up imaging and routine biopsy must be encouraged post-FT. While there is no reliable PSA threshold to predict failure after FT, reporting post-FT positive biopsies and retreatment rates appear to be standard when assessing treatment efficacy.